✨ Free AI Report
Arcutis Biotherapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Arcutis Biotherapeutics, Inc.
Research Preview

Arcutis Biotherapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Arcutis Biotherapeutics is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditi...

Analyst-debate audio for Arcutis Biotherapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Arcutis Biotherapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Arcutis Biotherapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Commercial-stage dermatology leader achieving profitability with blockbuster-potential ZORYVE demonstrating rapid expansion...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals / Medical Dermatology
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Arcutis Biotherapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Arcutis Biotherapeutics, Inc. Overview

Pro stress-test →

Arcutis Biotherapeutics is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis.

Strategic Profile

Pro stress-test →

Arcutis employs a precision-medicine approach to deliver topical therapies designed to improve efficacy and tolerability compared with existing treatment options. The company reported Q4 2025 net profit of US$17.4 million and raised 2026 net product revenue guidance to US$480 million–US$495 million, with rapid ZORYVE uptake across expanded indications translating into improving profitability.

Competitive Landscape

Pro stress-test →

Arcutis competes in the immuno-inflammatory skin disease market with clinical development efforts centered on targeted treatments for plaque psoriasis, atopic dermatitis, seborrheic dermatitis and vitiligo using a precision-medicine approach with topical therapies. Key competitors include JAK inhibitor manufacturers and other topical dermatology companies in the inflammatory skin disease space.

Industry Context

Arcutis Biotherapeutics, Inc. operates in Biopharmaceuticals / Medical Dermatology.

Key facts

Founded: 2016 · Headquarters: Westlake Village, United States · Revenue: $376.07M (2025 full-year) · Market cap: $3.50B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Arcutis Biotherapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Arcutis Biotherapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

JAK Inhibitors (Topical)Competing topical JAK inhibitor therapies for dermatological inflammation→PDE4 Inhibitors (Topical)Alternative phosphodiesterase-4 inhibitor options for psoriasis and dermatitis→Systemic BiologicsInjectable/systemic therapies for moderate-to-severe inflammatory skin disease→

Compare Arcutis Biotherapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Arcutis Biotherapeutics, Inc. operates in Biopharmaceuticals / Medical Dermatology. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals / Medical Dermatology research →
NEW · MCP server

Ask your AI assistant about Arcutis Biotherapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Arcutis Biotherapeutics, Inc. and its top competitor on Cyborg Score”
“What did Arcutis Biotherapeutics, Inc. do this quarter?”
“Is Arcutis Biotherapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Arcutis Biotherapeutics, Inc. do?+
Arcutis Biotherapeutics is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditi...
What is Arcutis Biotherapeutics, Inc.'s Cyborg Score?+
Arcutis Biotherapeutics, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Arcutis Biotherapeutics, Inc.'s main competitors?+
Named competitors include JAK Inhibitors (Topical), PDE4 Inhibitors (Topical), Systemic Biologics. The full competitive landscape is in the AskCyborg report.
How can I get the full Arcutis Biotherapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Arcutis Biotherapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Arcutis Biotherapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC